{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T17:03:28Z","timestamp":1792861408294,"version":"4.5.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002344","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T11:04:14Z","timestamp":1499425454000},"page":"e1002344","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":533,"title":["Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-9166","authenticated-orcid":true,"given":"Teodora","family":"Wi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Lahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ndowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4351-666X","authenticated-orcid":true,"given":"Jo-Anne R.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-2568","authenticated-orcid":true,"given":"Pilar","family":"Ramon-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0486-3255","authenticated-orcid":true,"given":"Sergey R.","family":"Eremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Bolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-2081","authenticated-orcid":true,"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"L Newman","year":"2015","journal-title":"PLoS ONE"},{"issue":"9995","key":"ref2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"T Vos","year":"2015","journal-title":"Lancet"},{"issue":"10009","key":"ref3","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: Quantifying the epidemiological transition","volume":"386","author":"CJ Murray","year":"2015","journal-title":"Lancet"},{"issue":"9069","key":"ref4","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","article-title":"Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1","volume":"349","author":"MS Cohen","year":"1997","journal-title":"Lancet"},{"key":"ref5","year":"2012"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in <italic>Neisseria gonorrhoeae<\/italic> in the 21st Century: Past, evolution, and future","volume":"27","author":"M Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2013the rapidly evolving <italic>Neisseria gonorrhoeae<\/italic> continues to challenge","volume":"15","author":"M Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: Gonorrhoea and <italic>Mycoplasma genitalium<\/italic>","volume":"14","author":"M Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"ref9","article-title":"WHO guidelines for the treatment of <italic>Neisseria gonorrhoeae<\/italic>","year":"2016"},{"issue":"RR-03","key":"ref10","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"KA Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"C Bignell","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref12","article-title":"Canadian guidelines on sexually transmitted infections","author":"B Romanowski","year":"2013"},{"key":"ref13","article-title":"Australian STI management guidelines for use in primary care","year":"2016"},{"key":"ref14","year":"2016"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/sextrans-2012-050674","article-title":"The serious threat of multidrug-resistant and untreatable gonorrhoea: The pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health","volume":"88","author":"F Ndowa","year":"2012","journal-title":"Sex Transm Infect"},{"key":"ref16","year":"2015"},{"key":"ref17","year":"1990"},{"key":"ref18","year":"1999"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO <italic>Neisseria gonorrhoeae<\/italic> reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes","volume":"63","author":"M Unemo","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/jac\/dkw288","article-title":"The novel 2016 WHO <italic>Neisseria gonorrhoeae<\/italic> reference strains for global quality assurance of laboratory investigations: Phenotypic, genetic and reference genome characterization","volume":"71","author":"M Unemo","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 4","key":"ref21","doi-asserted-by":"crossref","first-page":"iv16","DOI":"10.1136\/sextrans-2013-051117","article-title":"The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)\u2013a sentinel approach in the European Union (EU)\/European Economic Area (EEA)","volume":"89","author":"G Spiteri","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12879-015-1013-x","article-title":"Is the tide turning again for cephalosporin resistance in <italic>Neisseria gonorrhoeae<\/italic> in Europe? Results from the 2013 European surveillance","volume":"15","author":"MJ Cole","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"ref23","doi-asserted-by":"crossref","first-page":"iv5","DOI":"10.1136\/sextrans-2013-051162","article-title":"Trends in antimicrobial resistance in <italic>Neisseria gonorrhoeae<\/italic> in the USA: The Gonococcal Isolate Surveillance Project (GISP), January 2006 \u2013June 2012","volume":"89","author":"RD Kirkcaldy","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"<italic>Neisseria gonorrhoeae<\/italic> antimicrobial susceptibility surveillance\u2013The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014","volume":"65","author":"RD Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3201\/eid2201.151247","article-title":"Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in <italic>Neisseria gonorrhoeae<\/italic>, Canada","volume":"22","author":"I Martin","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.33321\/cdi.2015.39.39","article-title":"Australian Gonococcal Surveillance Programme. Australian Gonococcal Surveillance Programme annual report, 2014","volume":"39","author":"MM Lahra","year":"2015","journal-title":"Commun Dis Intell Q Rep"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/sextrans-2016-052583","article-title":"Drifting towards ceftriaxone treatment failure in gonorrhoea: Risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales","volume":"93","author":"K Town","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"Suppl 4","key":"ref28","doi-asserted-by":"crossref","first-page":"iv42","DOI":"10.1136\/sextrans-2012-050909","article-title":"Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union","volume":"89","author":"M Unemo","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"Suppl 4","key":"ref29","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1136\/sextrans-2012-050906","article-title":"Gonococcal antimicrobial resistance in the Western Pacific Region","volume":"89","author":"MM Lahra","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"Suppl 4","key":"ref30","first-page":"iv36","article-title":"Gonococcal Antimicrobial Surveillance Program Network in Latin America and the Caribbean 1990\u20132011. Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: Challenges and opportunities","volume":"89","author":"JA Dillon","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/OLQ.0000000000000587","article-title":"Resistance to ceftriaxone and azithromycin in <italic>Neisseria gonorrhoeae<\/italic> isolates from 7 countries of South America and the Caribbean: 2010\u20132011","volume":"44","author":"SD Thakur","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"Suppl 4","key":"ref32","doi-asserted-by":"crossref","first-page":"iv11","DOI":"10.1136\/sextrans-2012-050907","article-title":"Gonococcal antimicrobial resistance: Perspectives from the African region","volume":"89","author":"FJ Ndowa","year":"2013","journal-title":"Sex Transm Infect"},{"key":"ref33","article-title":"Strategies and laboratory methods for strengthening surveillance of sexually transmitted infections 2012","year":"2012"},{"issue":"Suppl 4","key":"ref34","doi-asserted-by":"crossref","first-page":"iv28","DOI":"10.1136\/sextrans-2012-050904","article-title":"Monitoring antimicrobial resistance in <italic>Neisseria gonorrhoeae<\/italic> in selected countries of the WHO South-East Asia Region between 2009 and 2012: A retrospective analysis","volume":"89","author":"M Bala","year":"2013","journal-title":"Sex Transm Infect"},{"key":"ref35","article-title":"ECDC surveillance report: Gonococcal antimicrobial susceptibility surveillance in Europe 2014","year":"2016"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea","volume":"13","author":"S Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval","volume":"9","author":"T Deguchi","year":"2003","journal-title":"J Infect Chemother"},{"issue":"47","key":"ref38","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"M Unemo","year":"2010","journal-title":"Euro Surveill"},{"issue":"14","key":"ref39","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England","volume":"16","author":"CA Ison","year":"2011","journal-title":"Euro Surveill"},{"issue":"43","key":"ref40","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.43.19998-en","article-title":"First <italic>Neisseria gonorrhoeae<\/italic> strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011","volume":"16","author":"M Unemo","year":"2011","journal-title":"Euro Surveill"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant <italic>N<\/italic>. <italic>gonorrhoeae<\/italic> in France: Novel <italic>penA<\/italic> mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"M Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"<italic>Neisseria gonorrhoeae<\/italic> treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"VG Allen","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/OLQ.0000000000000280","article-title":"Gonorrhea treatment failures with oral and injectable expanded spectrum cephalosporin monotherapy vs dual therapy at 4 Canadian sexually transmitted infection clinics, 2010\u20132013","volume":"42","author":"AE Singh","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dkt034","article-title":"Phenotypic and genetic characterization of the first two cases of extended-spectrum cephalosporin resistant <italic>Neisseria gonorrhoeae<\/italic> infection in South Africa and association with cefixime treatment failure","volume":"68","author":"DA Lewis","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is <italic>Neisseria gonorrhoeae<\/italic> initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"M Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 5","key":"ref46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","article-title":"Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods","volume":"58","author":"J Tapsall","year":"2009","journal-title":"J Med Microbiol"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea, Australia","volume":"68","author":"YM Chen","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1071\/SH13077","article-title":"One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia","volume":"10","author":"PJ Read","year":"2013","journal-title":"Sex Health"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"M Unemo","year":"2011","journal-title":"Euro Surveill"},{"issue":"30","key":"ref50","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.30.20862","article-title":"Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014","volume":"19","author":"D Golparian","year":"2014","journal-title":"Euro Surveill"},{"issue":"25","key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"M Unemo","year":"2012","journal-title":"Euro Surveill"},{"issue":"25","key":"ref52","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"H Fifer","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"ref53","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant <italic>Neisseria gonorrhoeae<\/italic> isolates detected in Catalonia, Spain","volume":"67","author":"J C\u00e1mara","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant <italic>Neisseria gonorrhoeae<\/italic>","volume":"7","author":"JW Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref55","article-title":"Progress report of the implementation of the global strategy for prevention and control of sexually transmitted infections: 2006\u20132015. Document for the World Health Assembly","year":"2015"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/sextrans-2014-051731","article-title":"Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant <italic>Neisseria gonorrhoeae<\/italic> strains?","volume":"91","author":"DA Lewis","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"9","key":"ref57","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciw864","article-title":"Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of <italic>Neisseria gonorrhoeae<\/italic> in a large health system","volume":"64","author":"LT Allan-Blitz","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrmicro3217","article-title":"Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance","volume":"12","author":"N Goire","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/QCO.0000000000000230","article-title":"Molecular tests for the detection of antimicrobial resistant <italic>Neisseria gonorrhoeae<\/italic>: When, where, and how to use?","volume":"29","author":"N Low","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/sextrans-2016-052753","article-title":"Antiseptic mouthwash against pharyngeal <italic>Neisseria gonorrhoeae<\/italic>: A randomised controlled trial and an in vitro study","volume":"93","author":"EP Chow","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"Suppl 4","key":"ref61","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1136\/sextrans-2013-051225","article-title":"Vaccine research for gonococcal infections: Where are we?","volume":"89","author":"AE Jerse","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/1040841X.2015.1105782","article-title":"Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development","volume":"42","author":"JL Edwards","year":"2016","journal-title":"Crit Rev Microbiol"},{"issue":"5","key":"ref63","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/JCM.00100-17","article-title":"<italic>Neisseria gonorrhoeae<\/italic> Sequence Typing for Antimicrobial Resistance (NG-STAR): A novel antimicrobial resistance multilocus typing scheme for tracking the global dissemination of <italic>N<\/italic>. <italic>gonorrhoeae<\/italic> strains","volume":"55","author":"W Demczuk","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JCM.02589-14","article-title":"Whole-genome phylogenomic heterogeneity of <italic>Neisseria gonorrhoeae<\/italic> isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013","volume":"53","author":"W Demczuk","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref65","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/JCM.03195-15","article-title":"Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant <italic>Neisseria gonorrhoeae<\/italic> in Canada from 1997 to 2014","volume":"54","author":"W Demczuk","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1473-3099(13)70693-5","article-title":"Genomic epidemiology of <italic>Neisseria gonorrhoeae<\/italic> with reduced susceptibility to cefixime in the USA: A retrospective observational study","volume":"14","author":"YH Grad","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ref67","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/jac\/dkw279","article-title":"WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC &gt;2 mg\/L) <italic>Neisseria gonorrhoeae<\/italic> isolates in Europe from 2009 to 2014","volume":"71","author":"S Jacobsson","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref68","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1473-3099(16)30157-8","article-title":"Whole-genome sequencing to determine transmission of <italic>Neisseria gonorrhoeae<\/italic>: An observational study","volume":"16","author":"D De Silva","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.7717\/peerj.806","article-title":"Population structure of <italic>Neisseria gonorrhoeae<\/italic> based on whole genome data and its relationship with antibiotic resistance","volume":"3","author":"MN Ezewudo","year":"2015","journal-title":"PeerJ"},{"issue":"10","key":"ref70","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/JCM.01502-14","article-title":"Using crude whole-genome assemblies of <italic>Neisseria gonorrhoeae<\/italic> as a platform for strain analysis: Clonal spread of gonorrhea infection in Saskatchewan, Canada","volume":"52","author":"S Vidovic","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref71","article-title":"WGS to predict antibiotic MICs for <italic>Neisseria gonorrhoeae<\/italic>","volume":"10","author":"DW Eyre","year":"2017","journal-title":"J Antimicrob Chemother"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:06:18Z","timestamp":1750503978000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002344","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731388302.793544006","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]}}}